{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:51:05Z","timestamp":1789044665294,"version":"build-2803163510"},"reference-count":172,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T00:00:00Z","timestamp":1621814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Malignant glioma represents a fatal disease with a poor prognosis and development of resistance mechanisms against conventional therapeutic approaches. The distinct tumor zones of this heterogeneous neoplasm develop their own microenvironment, in which subpopulations of cancer cells communicate. Adaptation to hypoxia in the center of the expanding tumor mass leads to the glycolytic and angiogenic switch, accompanied by upregulation of different glycolytic enzymes, transporters, and other metabolites. These processes render the tumor microenvironment more acidic, remodel the extracellular matrix, and create energy gradients for the metabolic communication between different cancer cells in distinct tumor zones. Escape mechanisms from hypoxia-induced cell death and energy deprivation are the result. The functional consequences are more aggressive and malignant behavior with enhanced proliferation and survival, migration and invasiveness, and the induction of angiogenesis. In this review, we go from the biochemical principles of aerobic and anaerobic glycolysis over the glycolytic switch, regulated by the key transcription factor hypoxia-inducible factor (HIF)-1\u03b1, to other important metabolic players like the monocarboxylate transporters (MCTs)1 and 4. We discuss the metabolic symbiosis model via lactate shuttling in the acidic tumor microenvironment and highlight the functional consequences of the glycolytic switch on glioma malignancy. Furthermore, we illustrate regulation by micro ribonucleic acids (miRNAs) and the connection between isocitrate dehydrogenase (IDH) mutation status and glycolytic metabolism. Finally, we give an outlook about the diagnostic and therapeutic implications of the glycolytic switch and the relation to tumor immunity in malignant glioma.<\/jats:p>","DOI":"10.3390\/ijms22115518","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T12:38:01Z","timestamp":1621859881000},"page":"5518","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["The Acidic Brain\u2014Glycolytic Switch in the Microenvironment of Malignant Glioma"],"prefix":"10.3390","volume":"22","author":[{"given":"Anna Maria","family":"Reuss","sequence":"first","affiliation":[{"name":"Laboratory for Translational Cell Biology and Neurooncology, Department of Neurosurgery, University Hospital Erlangen-N\u00fcrnberg, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominik","family":"Groos","sequence":"additional","affiliation":[{"name":"Institute of Physiology and Pathophysiology, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Buchfelder","sequence":"additional","affiliation":[{"name":"Laboratory for Translational Cell Biology and Neurooncology, Department of Neurosurgery, University Hospital Erlangen-N\u00fcrnberg, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1348-094X","authenticated-orcid":false,"given":"Nicolai","family":"Savaskan","sequence":"additional","affiliation":[{"name":"Laboratory for Translational Cell Biology and Neurooncology, Department of Neurosurgery, University Hospital Erlangen-N\u00fcrnberg, Friedrich-Alexander University Erlangen-N\u00fcrnberg (FAU), 91054 Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,5,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s11060-017-2607-5","article-title":"Epidemiology of glioma: Clinical characteristics, symptoms, and predictors of glioma patients grade I-IV in the the Danish Neuro-Oncology Registry","volume":"135","author":"Rasmussen","year":"2017","journal-title":"J. Neurooncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Davis, F.G., Smith, T.R., Gittleman, H.R., Ostrom, Q.T., Kruchko, C., and Barnholtz-Sloan, J.S. (2019). Glioblastoma incidence rate trends in Canada and the United States compared with England, 1995-2015. Neuro. Oncol.","DOI":"10.1093\/neuonc\/noz203"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/neuonc\/nop066","article-title":"Prevalence estimates for primary brain tumors in the United States by age, gender, behavior, and histology","volume":"12","author":"Porter","year":"2010","journal-title":"Neuro Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0163-7258(03)00014-7","article-title":"Current and future strategies for the treatment of malignant brain tumors","volume":"98","author":"Castro","year":"2003","journal-title":"Pharm. Ther."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bbrc.2011.02.123","article-title":"Elevated invasive potential of glioblastoma stem cells","volume":"406","author":"Cheng","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.hoc.2012.04.006","article-title":"Glioblastoma multiforme: Overview of current treatment and future perspectives","volume":"26","author":"Anton","year":"2012","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization Classification of Tumors of the Central Nervous System: A summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bpa.12832","article-title":"cIMPACT-NOW update 6: New entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading","volume":"30","author":"Louis","year":"2020","journal-title":"Brain Pathol."},{"key":"ref_9","first-page":"3930","article-title":"Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice","volume":"118","author":"Sonveaux","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/onc.2008.355","article-title":"Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions","volume":"28","author":"Mashima","year":"2009","journal-title":"Oncogene"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ijc.25009","article-title":"pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity","volume":"127","author":"Canese","year":"2010","journal-title":"Int. J. Cancer"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0021-9258(18)98125-1","article-title":"Regulatory mechanisms in carbohydrate metabolism. IV. Pasteur effect and Crabtree effect in ascites tumor cells","volume":"234","author":"Wu","year":"1959","journal-title":"J. Biol. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3389\/fphar.2011.00049","article-title":"Anticancer targets in the glycolytic metabolism of tumors: A comprehensive review","volume":"2","author":"Porporato","year":"2011","journal-title":"Front. Pharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/0470868716.ch17","article-title":"\u2018The metabolism of tumours\u2019: 70 years later","volume":"240","author":"Semenza","year":"2001","journal-title":"Novartis Found. Symp."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.1066373","article-title":"A conserved family of prolyl-4-hydroxylases that modify HIF","volume":"294","author":"Bruick","year":"2001","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"30772","DOI":"10.1074\/jbc.M304982200","article-title":"Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor","volume":"278","author":"Koivunen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"Maxwell","year":"1999","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1126\/science.1059817","article-title":"HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: Implications for O2 sensing","volume":"292","author":"Ivan","year":"2001","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"12969","DOI":"10.1073\/pnas.93.23.12969","article-title":"An essential role for p300\/CBP in the cellular response to hypoxia","volume":"93","author":"Arany","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","first-page":"5447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"12","author":"Semenza","year":"1992","journal-title":"Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1161\/01.RES.77.3.638","article-title":"Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5\u2032 enhancer","volume":"77","author":"Liu","year":"1995","journal-title":"Circ. Res."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1101\/gad.12.2.149","article-title":"Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha","volume":"12","author":"Iyer","year":"1998","journal-title":"Genes Dev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2006.02.002","article-title":"HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia","volume":"3","author":"Kim","year":"2006","journal-title":"Cell Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1042\/bj2500383","article-title":"Metabolism of pyruvate by isolated rat mesenteric lymphocytes, lymphocyte mitochondria and isolated mouse macrophages","volume":"250","author":"Curi","year":"1988","journal-title":"Biochem. J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1085\/jgp.8.6.519","article-title":"The metabolism of tumors in the body","volume":"8","author":"Warburg","year":"1927","journal-title":"J. Gen. Physiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: The metabolic requirements of cell proliferation","volume":"324","author":"Cantley","year":"2009","journal-title":"Science"},{"key":"ref_27","first-page":"56","article-title":"Bioenergetics and the problem of tumor growth","volume":"60","author":"Racker","year":"1972","journal-title":"Am. Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1074\/mcp.RA117.000154","article-title":"Proteome Analysis of Hypoxic Glioblastoma Cells Reveals Sequential Metabolic Adaptation of One-Carbon Metabolic Pathways","volume":"16","author":"Zhang","year":"2017","journal-title":"Mol. Cell Proteom."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"105546","DOI":"10.1016\/j.clineuro.2019.105546","article-title":"Serum lactate levels are associated with glioma malignancy grade","volume":"186","author":"Branco","year":"2019","journal-title":"Clin. Neurol. Neurosurg."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3290321","article-title":"Cloning and sequencing of four new mammalian monocarboxylate transporter (MCT) homologues confirms the existence of a transporter family with an ancient past","volume":"329","author":"Price","year":"1998","journal-title":"Biochem. J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/bj3430281","article-title":"The proton-linked monocarboxylate transporter (MCT) family: Structure, function and regulation","volume":"343","author":"Halestrap","year":"1999","journal-title":"Biochem. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/mr.58.1.71-93.1994","article-title":"Computer-aided analyses of transport protein sequences: Gleaning evidence concerning function, structure, biogenesis, and evolution","volume":"58","author":"Saier","year":"1994","journal-title":"Microbiol. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C761","DOI":"10.1152\/ajpcell.1993.264.4.C761","article-title":"Transport of lactate and other monocarboxylates across mammalian plasma membranes","volume":"264","author":"Poole","year":"1993","journal-title":"Am. J. Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/iub.573","article-title":"The monocarboxylate transporter family--Structure and functional characterization","volume":"64","author":"Halestrap","year":"2012","journal-title":"Iubmb Life"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"14624","DOI":"10.1074\/jbc.272.23.14624","article-title":"Interaction of the erythrocyte lactate transporter (monocarboxylate transporter 1) with an integral 70-kDa membrane glycoprotein of the immunoglobulin superfamily","volume":"272","author":"Poole","year":"1997","journal-title":"J. Biol. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3896","DOI":"10.1093\/emboj\/19.15.3896","article-title":"CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression","volume":"19","author":"Kirk","year":"2000","journal-title":"EMBO J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"27213","DOI":"10.1074\/jbc.M411950200","article-title":"Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: The ancillary protein for the insensitive MCT2 is EMBIGIN (gp70)","volume":"280","author":"Wilson","year":"2005","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/09687860600841967","article-title":"The role of charged residues in the transmembrane helices of monocarboxylate transporter 1 and its ancillary protein basigin in determining plasma membrane expression and catalytic activity","volume":"23","author":"Manoharan","year":"2006","journal-title":"Mol. Membr. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"20011","DOI":"10.1074\/jbc.M109.014217","article-title":"Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest a homology model of the open conformation and a plausible translocation cycle","volume":"284","author":"Wilson","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/(SICI)1520-6408(1997)21:4<268::AID-DVG4>3.0.CO;2-5","article-title":"Embigin, a developmentally expressed member of the immunoglobulin super family, is also expressed during regression of prostate and mammary gland","volume":"21","author":"Guenette","year":"1997","journal-title":"Dev. Genet."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/00001756-200103260-00030","article-title":"Expression of monocarboxylate transporter MCT1 in normal and neoplastic human CNS tissues","volume":"12","author":"Froberg","year":"2001","journal-title":"Neuroreport"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/neuonc\/nos298","article-title":"Monocarboxylate transporters (MCTs) in gliomas: Expression and exploitation as therapeutic targets","volume":"15","author":"Honavar","year":"2013","journal-title":"Neuro Oncol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6655529","DOI":"10.1155\/2021\/6655529","article-title":"MCT4 Promotes Tumor Malignancy in F98 Glioma Cells","volume":"2021","author":"Reuss","year":"2021","journal-title":"J. Oncol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/j.bbrc.2018.06.092","article-title":"Lactic acid induces lactate transport and glycolysis\/OXPHOS interconversion in glioblastoma","volume":"503","author":"Duan","year":"2018","journal-title":"Biochem. Biophys Res. Commun."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Grillon, E., Farion, R., Fablet, K., De Waard, M., Tse, C.M., Donowitz, M., Remy, C., and Coles, J.A. (2011). The spatial organization of proton and lactate transport in a rat brain tumor. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0017416"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s13402-012-0081-9","article-title":"Alterations of monocarboxylate transporter densities during hypoxia in brain and breast tumour cells","volume":"35","author":"Cheng","year":"2012","journal-title":"Cell Oncol. (Dordr.)"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9030","DOI":"10.1074\/jbc.M511397200","article-title":"The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism","volume":"281","author":"Ullah","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_48","first-page":"162","article-title":"Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?","volume":"1795","author":"Kaluz","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/s41388-019-1098-6","article-title":"CAIX forms a transport metabolon with monocarboxylate transporters in human breast cancer cells","volume":"39","author":"Ames","year":"2020","journal-title":"Oncogene"},{"key":"ref_50","first-page":"1194","article-title":"Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer","volume":"56","author":"Gerweck","year":"1996","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e4005","DOI":"10.1002\/nbm.4005","article-title":"CEST-MRI for glioma pH quantification in mouse model: Validation by immunohistochemistry","volume":"31","author":"Ferrauto","year":"2018","journal-title":"Nmr. Biomed."},{"key":"ref_52","first-page":"760","article-title":"Relationship of MR-derived lactate, mobile lipids, and relative blood volume for gliomas in vivo","volume":"26","author":"Li","year":"2005","journal-title":"Ajnr Am. J. Neuroradiol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kubelt, C., Peters, S., Ahmeti, H., Huhndorf, M., Huber, L., Cohrs, G., H\u00f6vener, J.B., Jansen, O., Synowitz, M., and Held-Feindt, J. (2020). Intratumoral Distribution of Lactate and the Monocarboxylate Transporters 1 and 4 in Human Glioblastoma Multiforme and Their Relationships to Tumor Progression-Associated Markers. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176254"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1002\/cncr.10767","article-title":"Modulation of growth and radiochemosensitivity of human malignant glioma cells by acidosis","volume":"95","author":"Reichert","year":"2002","journal-title":"Cancer"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"46335","DOI":"10.18632\/oncotarget.10114","article-title":"Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas","volume":"7","author":"Granja","year":"2016","journal-title":"Oncotarget"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/bj3330167","article-title":"Characterization of the monocarboxylate transporter 1 expressed in Xenopus laevis oocytes by changes in cytosolic pH","volume":"333","author":"Schneider","year":"1998","journal-title":"Biochem. J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"23111","DOI":"10.1074\/jbc.M202487200","article-title":"Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis","volume":"277","author":"Lu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1158\/0008-5472.CAN-05-4193","article-title":"Acid-mediated tumor invasion: A multidisciplinary study","volume":"66","author":"Gatenby","year":"2006","journal-title":"Cancer Res."},{"key":"ref_59","first-page":"125","article-title":"Elevated Lactate and Total Protein Levels in Stereotactic Brain Biopsy Specimen; Potential Biomarkers of Malignancy and Poor Prognosis","volume":"22","author":"Nikoobakht","year":"2019","journal-title":"Arch. Iran. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1038\/onc.2013.390","article-title":"Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner","volume":"33","author":"Lim","year":"2014","journal-title":"Oncogene"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0169(200012)47:4<319::AID-CM6>3.0.CO;2-I","article-title":"Intracellular pH modulation of ADF\/cofilin proteins","volume":"47","author":"Bernstein","year":"2000","journal-title":"Cell Motil. Cytoskelet."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1083\/jcb.201103045","article-title":"Cortactin phosphorylation regulates cell invasion through a pH-dependent pathway","volume":"195","author":"Magalhaes","year":"2011","journal-title":"J. Cell Biol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.1096\/fj.09-149518","article-title":"NHE1 promotes invadopodial ECM proteolysis through acidification of the peri-invadopodial space","volume":"24","author":"Busco","year":"2010","journal-title":"FASEB J."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00775-010-0680-8","article-title":"pH dependence of the enzymatic processing of collagen I by MMP-1 (fibroblast collagenase), MMP-2 (gelatinase A), and MMP-14 ectodomain","volume":"15","author":"Gioia","year":"2010","journal-title":"J. Biol. Inorg. Chem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fonc.2020.00183","article-title":"Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma","volume":"10","author":"Tao","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12576-016-0435-6","article-title":"Inhibition of monocarboxylate transporter 1 suppresses the proliferation of glioblastoma stem cells","volume":"66","author":"Takada","year":"2016","journal-title":"J. Physiol. Sci."},{"key":"ref_67","first-page":"208","article-title":"[The effect of downregulation of MCT1 on the proliferation of glioma cells]","volume":"41","author":"Zhou","year":"2019","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.humpath.2006.07.020","article-title":"Expression of hypoxia-related tissue factors in astrocytic gliomas. A multivariate survival study with emphasis upon carbonic anhydrase IX","volume":"38","author":"Korkolopoulou","year":"2007","journal-title":"Hum. Pathol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/neup.12485","article-title":"Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme","volume":"38","author":"Cetin","year":"2018","journal-title":"Neuropathology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/neuonc\/nos216","article-title":"Function of carbonic anhydrase IX in glioblastoma multiforme","volume":"14","author":"Proescholdt","year":"2012","journal-title":"Neuro Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Huang, B.R., Liu, Y.S., Lai, S.W., Lin, H.J., Shen, C.K., Yang, L.Y., and Lu, D.Y. (2020). CAIX Regulates GBM Motility and TAM Adhesion and Polarization through EGFR\/STAT3 under Hypoxic Conditions. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21165838"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1158\/1078-0432.CCR-11-1877","article-title":"Carbonic anhydrase IX promotes tumor growth and necrosis in vivo and inhibition enhances anti-VEGF therapy","volume":"18","author":"McIntyre","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/359845a0","article-title":"Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo","volume":"359","author":"Plate","year":"1992","journal-title":"Nature"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/jcp.20955","article-title":"Endothelial cell response to lactate: Implication of PAR modification of VEGF","volume":"211","author":"Kumar","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1073\/pnas.041359198","article-title":"Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability","volume":"98","author":"Fukumura","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"11368","DOI":"10.1074\/jbc.M108347200","article-title":"Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1\/2 MAPK signaling pathway: Mechanism of low pH-induced VEGF","volume":"277","author":"Xu","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Sonveaux, P., Copetti, T., De Saedeleer, C.J., Vegran, F., Verrax, J., Kennedy, K.M., Moon, E.J., Dhup, S., Danhier, P., and Frerart, F. (2012). Targeting the lactate transporter MCT1 in endothelial cells inhibits lactate-induced HIF-1 activation and tumor angiogenesis. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0033418"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1158\/0008-5472.CAN-10-2828","article-title":"Lactate influx through the endothelial cell monocarboxylate transporter MCT1 supports an NF-kappaB\/IL-8 pathway that drives tumor angiogenesis","volume":"71","author":"Vegran","year":"2011","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1002\/mc.22707","article-title":"Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk","volume":"56","author":"Bezerra","year":"2017","journal-title":"Mol. Carcinog."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"eaaz6119","DOI":"10.1126\/sciadv.aaz6119","article-title":"Label-free sensing of exosomal MCT1 and CD147 for tracking metabolic reprogramming and malignant progression in glioma","volume":"6","author":"Thakur","year":"2020","journal-title":"Sci. Adv."},{"key":"ref_81","first-page":"383","article-title":"The angiogenic switch leads to a metabolic shift in human glioblastoma","volume":"19","author":"Talasila","year":"2017","journal-title":"Neuro Oncol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1097\/SCS.0000000000001385","article-title":"miR-495 mediates metabolic shift in glioma cells via targeting Glut1","volume":"26","author":"Nie","year":"2015","journal-title":"J. Craniofac. Surg."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.molcel.2010.02.018","article-title":"MicroRNA-451 regulates LKB1\/AMPK signaling and allows adaptation to metabolic stress in glioma cells","volume":"37","author":"Godlewski","year":"2010","journal-title":"Mol. Cell"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Ogawa, D., Ansari, K., Nowicki, M.O., Sali\u0144ska, E., Bronisz, A., and Godlewski, J. (2019). MicroRNA-451 Inhibits Migration of Glioblastoma while Making It More Susceptible to Conventional Therapy. Noncoding RNA, 5.","DOI":"10.3390\/ncrna5010025"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"13751","DOI":"10.1007\/s13277-016-5219-3","article-title":"miRNA-451 inhibits glioma cell proliferation and invasion by downregulating glucose transporter 1","volume":"37","author":"Guo","year":"2016","journal-title":"Tumour. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.3892\/ijo.2017.3973","article-title":"The role of miR-451 in the switching between proliferation and migration in malignant glioma cells: AMPK signaling, mTOR modulation and Rac1 activation required","volume":"50","author":"Zhao","year":"2017","journal-title":"Int. J. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/humc.2018.133","article-title":"MiRNA-451 Inhibits Glioma Cell Proliferation and Invasion Through the mTOR\/HIF-1\u03b1\/VEGF Signaling Pathway by Targeting CAB39","volume":"29","author":"Nan","year":"2018","journal-title":"Hum. Gene Clin. Dev."},{"key":"ref_88","first-page":"1058","article-title":"MicroRNA-150 regulates glycolysis by targeting von Hippel-Lindau in glioma cells","volume":"9","author":"Li","year":"2017","journal-title":"Am. J. Transl Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1158\/0008-5472.CAN-13-2650","article-title":"Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1","volume":"74","author":"Bronisz","year":"2014","journal-title":"Cancer Res."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Tan, X., Wang, S., Yang, B., Zhu, L., Yin, B., Chao, T., Zhao, J., Yuan, J., Qiang, B., and Peng, X. (2012). The CREB-miR-9 negative feedback minicircuitry coordinates the migration and proliferation of glioma cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0049570"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-019-03275-z","article-title":"MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway","volume":"145","author":"Yang","year":"2019","journal-title":"J. Neurooncol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3892\/ijo.2015.3080","article-title":"Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2","volume":"47","author":"Fan","year":"2015","journal-title":"Int. J. Oncol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9962","DOI":"10.1074\/jbc.M111.332627","article-title":"Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells","volume":"287","author":"Xia","year":"2012","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/cdd.2013.196","article-title":"Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma","volume":"21","author":"Zhang","year":"2014","journal-title":"Cell Death Differ."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2012.01.029","article-title":"Over-expression of miR-145 enhances the effectiveness of HSVtk gene therapy for malignant glioma","volume":"320","author":"Lee","year":"2012","journal-title":"Cancer Lett."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1158\/0008-5472.CAN-13-1449","article-title":"microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma","volume":"74","author":"Kim","year":"2014","journal-title":"Cancer Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12935-020-1149-7","article-title":"MiR-181b suppress glioblastoma multiforme growth through inhibition of SP1-mediated glucose metabolism","volume":"20","author":"Yin","year":"2020","journal-title":"Cancer Cell Int."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00432-011-1114-x","article-title":"MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2","volume":"138","author":"Wang","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jso.23315","article-title":"MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma","volume":"108","author":"He","year":"2013","journal-title":"J. Surg Oncol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.18632\/aging.102576","article-title":"Circular RNA SMO sponges miR-338-3p to promote the growth of glioma by enhancing the expression of SMO","volume":"11","author":"Xiong","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s12031-020-01582-z","article-title":"MicroRNA-351 Promotes the Proliferation and Invasion of Glioma Cells through Downregulation of NAIF1","volume":"70","author":"Wu","year":"2020","journal-title":"J. Mol. Neurosci."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1186\/s13046-019-1483-6","article-title":"CircNFIX promotes progression of glioma through regulating miR-378e\/RPN2 axis","volume":"38","author":"Ding","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/neuonc\/now129","article-title":"miR-423-5p contributes to a malignant phenotype and temozolomide chemoresistance in glioblastomas","volume":"19","author":"Li","year":"2017","journal-title":"Neuro Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"135153","DOI":"10.1016\/j.neulet.2020.135153","article-title":"Down-regulation of circ-PTN suppresses cell proliferation, invasion and glycolysis in glioma by regulating miR-432-5p\/RAB10 axis","volume":"735","author":"Zhang","year":"2020","journal-title":"Neurosci. Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.brainres.2010.08.074","article-title":"MiRNA-451 plays a role as tumor suppressor in human glioma cells","volume":"1359","author":"Nan","year":"2010","journal-title":"Brain Res."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1080\/21691401.2019.1626404","article-title":"Knockdown of lncRNA LSINCT5 suppresses growth and metastasis of human glioma cells via up-regulating miR-451","volume":"47","author":"Liu","year":"2019","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/1078-0432.CCR-13-2284","article-title":"Primate-specific miR-663 functions as a tumor suppressor by targeting PIK3CD and predicts the prognosis of human glioblastoma","volume":"20","author":"Shi","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1038\/onc.2011.416","article-title":"Identification of additional IDH mutations associated with oncometabolite R(-)-2-hydroxyglutarate production","volume":"31","author":"Ward","year":"2012","journal-title":"Oncogene"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nature08617","article-title":"Cancer-associated IDH1 mutations produce 2-hydroxyglutarate","volume":"462","author":"Dang","year":"2009","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ccr.2010.12.014","article-title":"Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of \u03b1-ketoglutarate-dependent dioxygenases","volume":"19","author":"Xu","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/embor.2011.43","article-title":"The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases","volume":"12","author":"Chowdhury","year":"2011","journal-title":"EMBO Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ccr.2010.11.015","article-title":"Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation","volume":"18","author":"Figueroa","year":"2010","journal-title":"Cancer Cell"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1126\/science.1210944","article-title":"Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA","volume":"333","author":"He","year":"2011","journal-title":"Science"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1126\/science.1170944","article-title":"Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha","volume":"324","author":"Zhao","year":"2009","journal-title":"Science"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature10898","article-title":"Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation","volume":"483","author":"Koivunen","year":"2012","journal-title":"Nature"},{"key":"ref_117","first-page":"1184","article-title":"Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRI","volume":"21","author":"Yao","year":"2019","journal-title":"Neuro Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/neuonc\/not243","article-title":"Lactate dehydrogenase A silencing in IDH mutant gliomas","volume":"16","author":"Chesnelong","year":"2014","journal-title":"Neuro Oncol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"49165","DOI":"10.18632\/oncotarget.17106","article-title":"In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma","volume":"8","author":"Khurshed","year":"2017","journal-title":"Oncotarget"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Izquierdo-Garcia, J.L., Viswanath, P., Eriksson, P., Chaumeil, M.M., Pieper, R.O., Phillips, J.J., and Ronen, S.M. (2015). Metabolic reprogramming in mutant IDH1 glioma cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0118781"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.3174\/ajnr.A6633","article-title":"Lower Lactate Levels and Lower Intracellular pH in Patients with IDH-Mutant versus Wild-Type Gliomas","volume":"41","author":"Wenger","year":"2020","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.nicl.2016.06.018","article-title":"Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring","volume":"12","author":"Chaumeil","year":"2016","journal-title":"Neuroimage Clin."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"34942","DOI":"10.18632\/oncotarget.9006","article-title":"Mutant IDH1 expression is associated with down-regulation of monocarboxylate transporters","volume":"7","author":"Viswanath","year":"2016","journal-title":"Oncotarget"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/neuonc\/noz207","article-title":"Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas","volume":"22","author":"Malta","year":"2020","journal-title":"Neuro Oncol"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/s41467-017-00984-9","article-title":"Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xL","volume":"8","author":"Ishida","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.cmet.2015.06.009","article-title":"2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling","volume":"22","author":"Fu","year":"2015","journal-title":"Cell Metab."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"12700","DOI":"10.1038\/ncomms12700","article-title":"The oncometabolite 2-hydroxyglutarate activates the mTOR signalling pathway","volume":"7","author":"Carbonneau","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1091\/mbc.e06-07-0593","article-title":"Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase\/Akt regulation of Glut1 activity and trafficking","volume":"18","author":"Wieman","year":"2007","journal-title":"Mol. Biol. Cell"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"7315","DOI":"10.1128\/MCB.23.20.7315-7328.2003","article-title":"Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival","volume":"23","author":"Rathmell","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"3892","DOI":"10.1158\/0008-5472.CAN-03-2904","article-title":"Akt stimulates aerobic glycolysis in cancer cells","volume":"64","author":"Elstrom","year":"2004","journal-title":"Cancer Res."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1128\/MCB.22.20.7004-7014.2002","article-title":"Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin","volume":"22","author":"Hudson","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1158\/0008-5472.CAN-16-2773","article-title":"Chemosensitivity of IDH1-Mutated Gliomas Due to an Impairment in PARP1-Mediated DNA Repair","volume":"77","author":"Lu","year":"2017","journal-title":"Cancer Res."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/ars.2019.7902","article-title":"2-Hydroxyglutarate in Cancer Cells","volume":"33","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s13277-014-2644-z","article-title":"Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation","volume":"36","author":"Shi","year":"2015","journal-title":"Tumour. Biol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-013-1194-6","article-title":"Autophagy and oxidative stress in gliomas with IDH1 mutations","volume":"127","author":"Gilbert","year":"2014","journal-title":"Acta Neuropathol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1007\/s10495-013-0877-8","article-title":"Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death","volume":"18","author":"Mohrenz","year":"2013","journal-title":"Apoptosis"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s00259-017-3677-5","article-title":"[18F]-FMISO PET study of hypoxia in gliomas before surgery: Correlation with molecular markers of hypoxia and angiogenesis","volume":"44","author":"Bekaert","year":"2017","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Mapelli, P., Callea, M., Fallanca, F., Castellano, A., Bailo, M., Scifo, P., Bettinardi, V., Conte, G.M., Monterisi, C., and Rancoita, P.M.V. (2021). 18F-FAZA PET\/CT in pretreatment assessment of hypoxic status in high-grade glioma: Correlation with hypoxia immunohistochemical biomarkers. Nucl. Med. Commun.","DOI":"10.1097\/MNM.0000000000001396"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"Sadeghzadeh, M., Wenzel, B., G\u00fcndel, D., Deuther-Conrad, W., Toussaint, M., Moldovan, R.P., Fischer, S., Ludwig, F.A., Teodoro, R., and Jonnalagadda, S. (2020). Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging. Molecules, 25.","DOI":"10.3390\/molecules25102309"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1021\/acs.molpharmaceut.8b01210","article-title":"Targeting CAIX with [64 Cu]XYIMSR-06 Small Molecular Radiotracer Enables Noninvasive PET Imaging of Malignant Glioma in U87 MG Tumor Cell Xenograft Mice","volume":"16","author":"Yang","year":"2019","journal-title":"Mol. Pharm."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"e4044","DOI":"10.1002\/nbm.4044","article-title":"HDAC inhibition in glioblastoma monitored by hyperpolarized 13C MRSI","volume":"32","author":"Radoul","year":"2019","journal-title":"Nmr. Biomed."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.neuroscience.2003.08.040","article-title":"Highly differential expression of the monocarboxylate transporters MCT2 and MCT4 in the developing rat brain","volume":"122","author":"Rafiki","year":"2003","journal-title":"Neuroscience"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.cell.2011.02.018","article-title":"Astrocyte-neuron lactate transport is required for long-term memory formation","volume":"144","author":"Suzuki","year":"2011","journal-title":"Cell"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1593\/neo.11134","article-title":"Metabolic targeting of lactate efflux by malignant glioma inhibits invasiveness and induces necrosis: An in vivo study","volume":"13","author":"Colen","year":"2011","journal-title":"Neoplasia"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1038\/s41598-017-04612-w","article-title":"Disruption of the monocarboxylate transporter-4-basigin interaction inhibits the hypoxic response, proliferation, and tumor progression","volume":"7","author":"Voss","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"103657","DOI":"10.18632\/oncotarget.21761","article-title":"Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells","volume":"8","author":"Valbom","year":"2017","journal-title":"Oncotarget"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1227\/01.NEU.0000249218.65332.BF","article-title":"Metabolic remodeling of malignant gliomas for enhanced sensitization during radiotherapy: An in vitro study","volume":"59","author":"Colen","year":"2006","journal-title":"Neurosurgery"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ejpb.2016.09.018","article-title":"Inhibition of carbonic anhydrase IX in glioblastoma multiforme","volume":"109","author":"Amiri","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3171\/2014.10.JNS132363","article-title":"RNA interference targeting hypoxia-inducible factor 1\u03b1 via a novel multifunctional surfactant attenuates glioma growth in an intracranial mouse model","volume":"122","author":"Gillespie","year":"2015","journal-title":"J. Neurosurg."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10863-012-9409-4","article-title":"3-Bromopyruvate antagonizes effects of lactate and pyruvate, synergizes with citrate and exerts novel anti-glioma effects","volume":"44","author":"Shishido","year":"2012","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: An iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1093\/brain\/awx196","article-title":"Mammalian target of rapamycin complex 1 activation sensitizes human glioma cells to hypoxia-induced cell death","volume":"140","author":"Thiepold","year":"2017","journal-title":"Brain"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1038\/s41416-020-0814-x","article-title":"IDH mutation in glioma: Molecular mechanisms and potential therapeutic targets","volume":"122","author":"Han","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1038\/s41598-017-04023-x","article-title":"The prognostic significance of PD-L1 expression in patients with glioma: A meta-analysis","volume":"7","author":"Xue","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_155","first-page":"vdaa162","article-title":"Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1\/2 expression","volume":"3","author":"Givechian","year":"2021","journal-title":"Neurooncol. Adv."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"640720","DOI":"10.3389\/fonc.2021.640720","article-title":"UCP2 as a Potential Biomarker for Adjunctive Metabolic Therapies in Tumor Management","volume":"11","author":"Vallejo","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2013.04.005","article-title":"Metabolic pathways in immune cell activation and quiescence","volume":"38","author":"Pearce","year":"2013","journal-title":"Immunity"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.it.2014.12.004","article-title":"Targeting T cell metabolism for therapy","volume":"36","author":"Pearce","year":"2015","journal-title":"Trends Immunol."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/ijc.25543","article-title":"Warburg phenotype in renal cell carcinoma: High expression of glucose-transporter 1 (GLUT-1) correlates with low CD8(+) T-cell infiltration in the tumor","volume":"128","author":"Singer","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.cell.2015.08.016","article-title":"Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression","volume":"162","author":"Chang","year":"2015","journal-title":"Cell"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.immuni.2009.10.010","article-title":"The mTOR kinase determines effector versus memory CD8+ T cell fate by regulating the expression of transcription factors T-bet and Eomesodermin","volume":"32","author":"Rao","year":"2010","journal-title":"Immunity"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1158\/0008-5472.CAN-13-0992","article-title":"A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells","volume":"74","author":"Barsoum","year":"2014","journal-title":"Cancer Res."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.cell.2015.08.052","article-title":"Melanoma Cell-Intrinsic PD-1 Receptor Functions Promote Tumor Growth","volume":"162","author":"Kleffel","year":"2015","journal-title":"Cell"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De Novo Epigenetic Programs Inhibit PD-1 Blockade-Mediated T Cell Rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/neuonc\/noz117","article-title":"Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma","volume":"21","author":"Cui","year":"2019","journal-title":"Neuro. Oncol."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Roesch, S., Rapp, C., Dettling, S., and Herold-Mende, C. (2018). When Immune Cells Turn Bad-Tumor-Associated Microglia\/Macrophages in Glioma. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19020436"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.15252\/embr.201744154","article-title":"Branched-chain ketoacids secreted by glioblastoma cells via MCT1 modulate macrophage phenotype","volume":"18","author":"Silva","year":"2017","journal-title":"EMBO Rep."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/cas.14408","article-title":"Tumor-associated macrophage interleukin-\u03b2 promotes glycerol-3-phosphate dehydrogenase activation, glycolysis and tumorigenesis in glioma cells","volume":"111","author":"Lu","year":"2020","journal-title":"Cancer Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.18632\/oncotarget.2838","article-title":"Dichloroacetate blocks aerobic glycolytic adaptation to attenuated measles virus and promotes viral replication leading to enhanced oncolysis in glioblastoma","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/5518\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:06:39Z","timestamp":1760162799000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/11\/5518"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,24]]},"references-count":172,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,6]]}},"alternative-id":["ijms22115518"],"URL":"https:\/\/doi.org\/10.3390\/ijms22115518","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,24]]}}}